HC Q study #70
See all studies
7/22
Negative
Late treatment study
Kelly et al., British Journal of Clinical Pharmacology, doi:10.1111/bcp.14482 (Peer Reviewed)
Clinical outcomes and adverse events in patients hospitalised with COVID‐19, treated with off‐label hydroxych loroquine and azithromycin
Retrospective 82 hospitalized patients HC Q/AZ, 52 SOC, not finding statistically significant differences. Confounding by indication. No attempt to adjust for confounders. HC Q/AZ patients were more severely ill with higher C‐reactive protein and fraction of inspired oxygen requirements at baseline.
Source   Share   Tweet
See all studies
Please send us corrections, updates, or comments.
Submit